Interstitial Doppler optical coherence tomography as a local tumor necrosis predictor in photodynamic therapy of prostatic carcinoma: An in vivo study

Cancer Research

Volumn 68, Issue 23, 2008, Pages 9987-9995

  Standish, Beau A ^a   Lee, Kenneth K C ^a   Jin, Xiao ^b   Mariampillai, Adrian ^a   Munce, Nigel R ^a   Wood, Michael F G ^a   Wilson, Brian C ^a,b   Vitkin, I Alex ^a,b   Yang, Victor X D ^b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c RYERSON UNIVERSITY   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOWMETRY; CALCULATION; CANCER RADIOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; IN VIVO STUDY; INTERSTITIAL DOPPLER OPTICAL COHERENCE TOMOGRAPHY; MALE; MICROVASCULARIZATION; MONTE CARLO METHOD; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUANTITATIVE ANALYSIS; RAT; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR NECROSIS; XENOGRAFT;

ANIMALS; DIHEMATOPORPHYRIN ETHER; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MODELS, BIOLOGICAL; MONTE CARLO METHOD; NECROSIS; PHOTOCHEMOTHERAPY; PROSTATIC NEOPLASMS; RATS; TOMOGRAPHY, OPTICAL COHERENCE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 57149104935     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1128     Document Type: Article

References (57)

1. Overholt BF, Wang KK, Burdick JS, et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc 2007;66:460-8.
2. Lou PJ , Jones L, Hopper C. Clinical outcomes of photodynamic therapy for head-and-neck cancer. Technol Cancer Res Treat 2003;2:311-7.
3. Huang Z. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 2005;4:283-93.
4. Wolfsen HC. Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus. J Clin Gastroenterol 2005;39:653-64.
5. Trachtenberg J, Bogaards A, Weersink RA, et al. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. J Urol 2007;178:1974-9.
6. Szeimies RM, Morton CA, Sidoroff A, Braathen LR. Photodynamic therapy for non-melanoma skin cancer. Acta Dermatol Venereologica 2005;85:483-90.
7. Muller PJ, Wilson BC. Photodynamic therapy of brain tumors - a work in progress. Lasers Surg Med 2006;38:384-9.
8. Akens MK, Yee AJM, Wilson BC, et al. Photodynamic therapy of vertebral metastases: evaluating tumor-to-neural tissue uptake of BPD-MA and ALA-PpIX in a murine model of metastatic human breast carcinoma. Photochem Photobiol 2007;83:1034-9.
9. Standish BA, Jin X, Smolen J, et al. Interstitial Doppler optical coherence tomography monitors microvascular changes during photodynamic therapy in a Dunning prostate model under varying treatment conditions. J Biomed Opt 2007;12:034022.
10. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
11. Canadian Cancer Society/National Cancer Institute of Canada: Canadian Cancer Statistics 2007. Toronto: Canadian Cancer Society/National Cancer Institute of Canada; 2007. p. 4.
12. CancerStats Incidence - UK. London: Cancer Research UK; 2006. p. 2.
13. Du KL, Mick R, Busch TM, et al. Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer. Lasers Surg Med 2006;38:427-34.
14. Nathan TR, Whitelaw DE, Chang SC, et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J Urol 2002;168:1427-32.
15. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photo inactivation of a murine tumor. Cancer Res 1976;36:2326-9.
16. Huang Z, Chen Q, Dole KC, et al. The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues - in vivo study in a canine model. Photochem Photobiol Sci 2007;6:1318-24.
17. Sunar U, Makonnen S, Zhou C, et al. Hemodynamic responses to antivascular therapy and ionizing radiation assessed by diffuse optical spectroscopies. Optics Exp 2007;15:15507-16.
18. Zhou C, Choe R, Shah N, et al. Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy. J Biomed Opt 2007;12:3543-52.
19. Yu G, Durduran T, Zhou C, et al. Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy. Clin Cancer Res 2005;11:3543-52.
20. Yazdanfar S, Kulkarni MD, Izatt JA. High resolution imaging of in vivo cardiac dynamics using color Doppler optical coherence tomography. Optics Exp 1997;1:424-31.
21. Chen Z, Milner TE, Dave D, Nelson JS. Optical Doppler tomographic imaging of fluid flow velocity in highly scattering media. Optics Lett 1997;22:64-6.
22. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-81.
23. Yazdanfar S, Rollins AM, Izatt JA. Imaging and velocimetry of the human retinal circulation with color Doppler optical coherence tomography. Optics Lett 2000;25:1448-50.
24. Vakoc BJ, Yun SH, De Boer JF, Tearney GJ, Bouma BE. Phase-resolved optical frequency domain imaging. Opt Exp 2005;13:5483-93.
25. Schaefer AW, Reynolds JJ, Marks DL, Boppart SA. Real-time digital signal processing-based optical coherence tomography and doppler optical coherence tomography. IEEE Transact Biomed Eng 2004;51:186-90.
26. Zhao Y, Chen Z, Saxer C, Xiang S, De Boer JF, Nelson JS. Phase-resolved optical coherence tomography and optical Doppler tomography for imaging blood flow in human skin with fast scanning speed and high velocity sensitivity. Opt Lett 2000;25:114-6.
27. Yang VXD, Tang SJ, Gordon ML, et al. Endoscopic Doppler optical coherence tomography in the human GI tract: initial experience. Gastrointest Endosc 2005;61:879-90.
28. Cense B, Chen TC, Nassif N, et al. Ultra-high speed and ultra-high resolution spectral-domain optical coherence tomography and optical Doppler tomography in ophthalmology. Bull Société Belge d'Ophtalmologie 2006;302:123-32.
29. Skliarenko JV, Lunt SJ, Gordon ML, Vitkin A, Milosevic M, Hill RP. Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumors. Cancer Res 2006;66:2074-80.
30. Chen Z, Milner TE, Wang X, Srinivas S, Nelson JS. Optical Doppler tomography: imaging in vivo blood flow dynamics following pharmacological intervention and photodynamic therapy. Photochem Photobiol 1998;67:56-60.
31. Aalders MCG, Triesscheijn M, Ruevekamp M, et al. Doppler optical coherence tomography to monitor the effect of photodynamic therapy on tissue morphology and perfusion. J Biomed Opt 2006;11:044011.
32. Standish BA, Yang VXD, Munce NR, et al. Doppler optical coherence tomography monitoring of microvascular tissue response during photodynamic therapy in an animal model of Barrett's esophagus. Gastrointest Endosc 2007;66:326-33.
33. Collins HAKM, Moriyama ED, Mariampillai A, Dahlstedt E, Balaz M, Kuimova MK. Blood-vessel closure using photosensitizers engineered for two-photon excitation. Nat Photon 2008;2:420-4.
34. Li H, Standish BA, Mariampillai A, et al. Feasibility of interstitial doppler optical coherence tomography for in vivo detection of microvascular changes during photodynamic therapy. Lasers Surg Med 2006;38:754-61.
35. Yang VXD, Gordon ML, Qi B, et al. High speed, wide velocity dynamic range Doppler optical coherence tomography (Part I): system design, signal processing, and performance. Opt Exp 2003;11:794-809.
36. Yang VXD, Gordon ML, Mok A, et al. Improved phase-resolved optical Doppler tomography using the Kasai velocity estimator and histogram segmentation. Opt Commun 2002;208:209-14.
37. Roy M, DaCosta RS, Weersink R, et al. Quantum dots as contrast agents for endoscopy: Mathematical modeling and experimental validation of the optimal excitation wavelength. SPIE 2007;8:644812.
38. Dam JS, Dalgaard T, Fabricius PE, Andersson-Engels S. Multiple polynomial regression method for determination of biomedical optical properties from integrating sphere measurements. Appl Opt 2000;39:1202-9.
39. Wilson B. Measurements of tissue optical properties: Methods and theories. In: AJ Welch MvG, editor. Optical-Thermal Response of Laser-Irradiated Tissue. New York: Plenum Press; 1995. p. 233-305.
40. Jacques SLWL. Monte Carlo Modeling of Light Transport in Tissues. In: Welch AJMvG, editor. Optical-Thermal Response of Laser-Irradiated Tissue. New York: Plenum Press; 1995. p. 73-99.
41. Jacques SL. Simple optical theory for light dosimetry during PDT. SPIE 1992;1645:155-65.
42. Busch TM, Wileyto EP, Emanuele MJ, et al. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen. Cancer Res 2002;62:7273-9.
43. Johansson A, Axelsson J, Andersson-Engels S, Swartling J. Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate. Med Phys 2007;34:4309-21.
44. Huang Z, Chen Q, Luck D, et al. Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer. Lasers Surg Med 2005;36:390-7.
45. Svensson T, Andersson-Engels S, Einarsdóttír M, Svanberg K. In vivo optical characterization of human prostate tissue using near-infrared time-resolved spectroscopy. J Biomed Opt 2007;12:014022.
46. Zhu TC, Finlay JC, Hahn SM. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J Photochem Photobiol B 2005;79:231-41.
47. Solonenko M, Cheung R, Busch TM, et al. In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates. Phys Med Biol 2002;47:857-73.
48. Wang HW, Putt ME, Emanuele MJ, et al. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome. Cancer Res 2004;64:7553-61.
49. Kruijt B, De Bruijn HS, Van Der Ploeg - Van Den Heuvel A, Sterenborg HJCM, Robinson DJ. Laser speckle imaging of dynamic changes in flow during photodynamic therapy. Lasers Med Sci 2006;21:208-12.
50. Ohlerth S, Laluhova D, Buchholz J, Roos M, Walt H, Kaser-Hotz B. Changes in vascularity and blood volume as a result of photodynamic therapy can be assessed with power Doppler ultrasonography. Lasers Surg Med 2006;38:229-34.
51. Powers BE, Withrow SJ, Thrall DE, et al. Percent tumor necrosis as a predictor of treatment response in canine osteosarcoma. Cancer 1991;67:126-34.
52. Leach RM, Hill HS, Snetkov VA, Ward JPT. Hypoxia, energy state and pulmonary vasomotor tone. Respir Physiol Neurobiol 2002;132:55-67.
53. Khurana M, Moriyama EH, Mariampillai A, Wilson BC. Intravital high resolution optical imaging of individual vessel response to photodynamic treatment. J Biomed Opt 2008;13:040502.
54. Mariampillai A, Standish BA, Moriyama EH, et al. Speckle Variance Detection of Microvasculature using Swept Source Optical Coherence Tomography. Opt Lett 2008;33:1530-2.
55. Luo Y, Arauz LJ, Castillo JE, Barton JK, Kostuk RK. Parallel optical coherence tomography system. Applied Opt 2007;46:8291-7.
56. Vakoc BJ, Shishko M, Yun SH, et al. Comprehensive esophageal microscopy by using optical frequency-domain imaging (with video). Gastrointest Endosc 2007;65:898-905.
57. Wilson BC. Detection and treatment of dysplasia in Barrett's esophagus: A pivotal challenge in translating biophotonics from bench to bedside. J Biomed Opt 2007;12:051401.